![Jan Peter Olofsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan Peter Olofsson
Oprichter bij
Redoxis AB
Profiel
Peter Olofsson is the founder of Redoxis AB, founded in 2007, holding the title of Director.
Dr. Olofsson is currently the Chief Executive Officer of ProNoxis AB since 2012.
Former positions include Principal at Biovitrum AB and Principal at Arexis AB. Education includes a doctorate from the University of Lund and an MBA from the University of Gothenburg.
Actieve functies van Jan Peter Olofsson
| Bedrijven | Functie | Begin |
|---|---|---|
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Oprichter | 01-01-2007 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Algemeen Directeur | - |
Eerdere bekende functies van Jan Peter Olofsson
| Bedrijven | Functie | Einde |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Directeur/Bestuurslid | 31-12-2009 |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Opleiding van Jan Peter Olofsson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
